The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for SYD-101 (atropine sulfate) to slow the progression of myopia ... for other eye problems including ...

Whether atropine should be the standard of care for halting myopia progression was a hot topic discussed at the Congress on Controversies in Ophthalmology.

Children with myopia using 0.05% atropine eye drops had less myopia progression and/or less axial elongation compared with ...

These lenses have been shown to reduce myopia progression on average by about 50 percent. Atropine: These eye drops are taken in each eye before bed. It is currently not known how this medication ...

A five-year clinical study has revealed that spectacle lenses equipped with highly aspherical lenslets (HAL) can ...

The EMA’s Committee for Medicinal Products for Human Use said that a phase 3 study in children aged 3-14 years demonstrated ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

Suggested remit: To appraise the clinical and cost effectiveness of low-dose atropine eye drops within its marketing authorisation for treating myopia in people 3 to 14 years.

A landmark five-year clinical study has revealed that spectacle lenses equipped with highly aspherical lenslets (HAL) can ...

In children, unchecked progression often leads to high myopia, which dramatically raises the risk of irreversible vision impairment. Current interventions—such as atropine eye drops and ...